Literature DB >> 23903761

[Questions from a pain physician reader: Evidence, empiricism, eminence - all the same?].

W Meißner, F Petzke, R Sabatowski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23903761     DOI: 10.1007/s00482-013-1341-y

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


× No keyword cloud information.
  8 in total

1.  Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years.

Authors:  Martin C Michel; Piotr Radziszewski; Christian Falconer; Daniela Marschall-Kehrel; Koenraad Blot
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

Review 2.  Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.

Authors:  Augusto Caraceni; Geoffrey Hanks; Stein Kaasa; Michael I Bennett; Cinzia Brunelli; Nathan Cherny; Ola Dale; Franco De Conno; Marie Fallon; Magdi Hanna; Dagny Faksvåg Haugen; Gitte Juhl; Samuel King; Pål Klepstad; Eivor A Laugsand; Marco Maltoni; Sebastiano Mercadante; Maria Nabal; Alessandra Pigni; Lukas Radbruch; Colette Reid; Per Sjogren; Patrick C Stone; Davide Tassinari; Giovambattista Zeppetella
Journal:  Lancet Oncol       Date:  2012-02       Impact factor: 41.316

Review 3.  Breakthrough pain: progress in management.

Authors:  Dominique A Lossignol; Cristina Dumitrescu
Journal:  Curr Opin Oncol       Date:  2010-07       Impact factor: 3.645

Review 4.  Treatment strategies for cancer patients with breakthrough pain.

Authors:  Alessandra Casuccio; Sebastiano Mercadante; Fabio Fulfaro
Journal:  Expert Opin Pharmacother       Date:  2009-04       Impact factor: 3.889

5.  The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland.

Authors:  Andrew N Davies; Andrew Dickman; Colette Reid; Anna-Marie Stevens; Giovambattista Zeppetella
Journal:  Eur J Pain       Date:  2008-08-15       Impact factor: 3.931

Review 6.  Opioids for the management of breakthrough cancer pain in adults: a systematic review undertaken as part of an EPCRC opioid guidelines project.

Authors:  Giovambattista Zeppetella
Journal:  Palliat Med       Date:  2011-07       Impact factor: 4.762

7.  Analgesic efficacy and tolerability of flupirtine vs. tramadol in patients with subacute low back pain: a double-blind multicentre trial*.

Authors:  C Li; J Ni; Z Wang; M Li; M Gasparic; B Terhaag; M A Uberall
Journal:  Curr Med Res Opin       Date:  2008-12       Impact factor: 2.580

8.  Opioids for cancer breakthrough pain: a pilot study reporting patient assessment of time to meaningful pain relief.

Authors:  Giovambattista Zeppetella
Journal:  J Pain Symptom Manage       Date:  2008-02-06       Impact factor: 3.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.